Alan Kaplan
- Patient experiences of exacerbations in a real world setting: Global results from the Hidden Depths surveyBy Neil Barnes, Peter M.A. Calverley, Alan Kaplan and Klaus F. RabeNeil Barnes1Department of Respiratory Medicine, London Chest Hospital, London, United KingdomPeter M.A. Calverley2School of Clinical Sciences, University Hospital Aintree, Liverpool, United KingdomAlan Kaplan3Bedford Park Medical Centre, Richmond Hill, ON, CanadaKlaus F. Rabe4University Kiel, Department of Medicine and Krankenhaus Grosshansdorf, Center for Pulmonology and Thoracic Surgery, D-22927 Grosshansdorf, Germany
- In whom should regular asthma controller therapy be initiated?By Alan Kaplan, Nadia Grillo, Louis-Phillipe Boulet and Samir GuptaAlan Kaplan1Community and Family Medicine, University of Toronto, Toronto, ON, CanadaNadia Grillo2Respirology, University of Toronto, Toronto, ON, CanadaLouis-Phillipe Boulet3Cardiology and Pulmonology, Laval University, Sainte-Foy, QC, CanadaSamir Gupta2Respirology, University of Toronto, Toronto, ON, Canada
- Spirometry interpretation for primary care: A validation studyBy Alan Kaplan and Jade LernerAlan Kaplan1Family Medicine, Brampton Civic Hospital, Brampton, ON, CanadaJade Lerner1Family Medicine, Brampton Civic Hospital, Brampton, ON, Canada
- How well can we practically apply asthma guidelines?By Alan Kaplan, Nadia Griller, Louis Phillipe Boulet and Samir GuptaAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaNadia Griller2Respiratory Medicine, University of Toronto, Toronto, ON, CanadaLouis Phillipe Boulet3Cardiology and Pulmonology, Laval University, Sainte-Foy, QC, CanadaSamir Gupta2Respiratory Medicine, University of Toronto, Toronto, ON, Canada
- Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD managementBy Alan Kaplan and Marie-Andree CyrAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaMarie-Andree Cyr2Research, Novartis Pharmaceuticals, Montreal, QC, Canada
- GP survey on how to incorporate LABA/LAMA fixed dose combinations (FDC) in their COPD patientsBy Alan Kaplan, David Hill and Marie-Andree CyrAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaDavid Hill2Research, Ventures in Research, Castlemore, ON, CanadaMarie-Andree Cyr3Research, Novartis Pharmaceuticals, Montreal, QC, Canada
- Family physicians step therapy up in symptomatic COPD patients differently than respiratory specialistsBy Alan Kaplan and Marie-Andree CyrAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaMarie-Andree Cyr2Research, Novartis Pharaceuticals, Montreal, QC, Canada
- Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trialsBy Alan Kaplan, George Zhanel, Christina Calciu and Wolter KevinAlan Kaplan1Family and Community Medicine, University of Toronto, Toronto, ON, CanadaGeorge Zhanel2Medical Microbiology/Infectious Diseases, Faculty of Medicine, University of Manitoba, Winnipeg, MB, CanadaChristina Calciu3Research, Pfizer Canada, Montreal, QC, CanadaWolter Kevin4Research, Pfizer United States, New York, NY,
- Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbationsBy Mike Thomas, David Price, John Blakey, Lynn Josephs, Ian Pavord, Borislav Dimitrov, Dirkje Postma, Alberto Papi, Alexandra Dima, Todor Popov, Hilary Pinnock, Iain Small, Alan Kaplan, Cynthia Rand, Janet Holbrook, Emilio Pizzichini, Gene Colice, Sam Walker, Annie Burden and Vasilis NikolaouMike Thomas1Primary Medical Care, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomDavid Price2Research in Real Life, RiRL, Singapore, Singapore18Research in Real Life, RiRL, Cambridge, United Kingdom19Centre for Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomJohn Blakey3Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomLynn Josephs1Primary Medical Care, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomIan Pavord4Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomBorislav Dimitrov5Faculty of Medicine, University of Southampton, Southampton, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomDirkje Postma6University of Groningen, University Medical Center Groningen, Groningen, Netherlands20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlberto Papi7Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlexandra Dima8Communication Science, University of Amsterdam, Amsterdam, Netherlands20Respiratory Effectiveness Group, REG, Cambridge, United KingdomTodor Popov9Clinic of Allergy & Asthma, Medical University Sofia, Sofia, Bulgaria20Respiratory Effectiveness Group, REG, Cambridge, United KingdomHilary Pinnock10Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomIain Small11Peterhead Medical Practice, Health Centre, Peterhead, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAlan Kaplan12Family and Community Medicine, University of Toronto, Toronto, Canada20Respiratory Effectiveness Group, REG, Cambridge, United KingdomCynthia Rand13Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomJanet Holbrook14Epidemiology, Johns Hopkins University, Baltimore, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomEmilio Pizzichini15Clinical Medicine, Federal University of Santa Catarina, Florianopolis, Brazil20Respiratory Effectiveness Group, REG, Cambridge, United KingdomGene Colice16School of Medicine, George Washington University, Washington DC, United States20Respiratory Effectiveness Group, REG, Cambridge, United KingdomSam Walker17Research and Policy, Asthma UK, London, United Kingdom20Respiratory Effectiveness Group, REG, Cambridge, United KingdomAnnie Burden18Research in Real Life, RiRL, Cambridge, United KingdomVasilis Nikolaou18Research in Real Life, RiRL, Cambridge, United Kingdom
- Alan KaplanCommunity and Family Medicine, University of Toronto, Toronto, ON Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.